News & Analysis on Clinical Trial Services & Contract Research And Development
QuantHealth announced it has raised a $15 million series A funding round today (August 22) for its clinical simulator that can predict how a patient will respond to treatment in a clinical trial.
Actimed Therapeutics Ltd will put some of its additional funding of £4.75 million ($6 million) towards its attempt to provide the world’s first cure for cancer cachexia.
Hutchmed is planning to submit a New Drug Application (NDA) for treatment of primary immune thrombocytopenia (ITP) in China.
Those in the life sciences industry needing some creative input can now turn to Bios Health Group who have recently launched into the space.